| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 29/08/2007 | 22:45 | PR Newswire (US) | American Stock Exchange Lists Merrill Lynch's 12% Callable STRIDES Linked To Apple, Inc. | AMEX:AVN | |
| 01/02/2006 | 14:00 | PR Newswire (US) | Dr. Gerald Yakatan, Former President and CEO of Avanir Pharmaceuticals, Joins Cobalis Corp. Board of Directors | AMEX:AVN | |
| 17/01/2006 | 22:15 | Business Wire | AVANIR Implements One-for-Four Reverse Stock Split and New Stock Ticker Symbol | AMEX:AVN | 12% Strides Linked TO Apple, Inc. |
| 11/01/2006 | 14:35 | Business Wire | AVANIR Licenses Docosanol 10% Cream in Japan | AMEX:AVN | 12% Strides Linked TO Apple, Inc. |
| 11/01/2006 | 14:30 | Business Wire | AVANIR Pharmaceuticals Hires Randall E. Kaye, M.D. as Vice President of Medical Affairs | AMEX:AVN | 12% Strides Linked TO Apple, Inc. |
| 06/01/2006 | 13:30 | Business Wire | AVANIR's Board of Directors Approves the Implementation of a One-for-Four Reverse Stock Split | AMEX:AVN | 12% Strides Linked TO Apple, Inc. |
| 04/01/2006 | 22:00 | Business Wire | AVANIR Pharmaceuticals Invites Investors to the 24th Annual JPMorgan Healthcare Conference Webcast | AMEX:AVN | 12% Strides Linked TO Apple, Inc. |
| 03/01/2006 | 14:30 | Business Wire | Phase I Reverse Cholesterol Transport Trial Initiated; AVANIR to Receive $5 Million Milestone | AMEX:AVN | 12% Strides Linked TO Apple, Inc. |
| 23/11/2005 | 22:10 | Business Wire | AVANIR Pharmaceuticals Invites Investors to the Lazard Capital Markets Life Sciences Conference Webcast | AMEX:AVN | 12% Strides Linked TO Apple, Inc. |
| 14/11/2005 | 15:00 | Business Wire | AVANIR Pharmaceuticals Appoints Scott M. Whitcup, M.D., to Board of Directors | AMEX:AVN | 12% Strides Linked TO Apple, Inc. |
| 02/11/2005 | 22:56 | Business Wire | AVANIR Pharmaceuticals Invites Investors to the CIBC and the Rodman & Renshaw Healthcare Conference Webcasts | AMEX:AVN | 12% Strides Linked TO Apple, Inc. |
| 18/10/2005 | 20:14 | Business Wire | AVANIR Announces $16 Million Common Stock Offering | AMEX:AVN | 12% Strides Linked TO Apple, Inc. |
| 27/09/2005 | 15:00 | Business Wire | AVANIR Pharmaceuticals Appoints Craig Wheeler to Board Of Directors | AMEX:AVN | 12% Strides Linked TO Apple, Inc. |
| 22/09/2005 | 14:00 | Business Wire | Further Update on AVANIR's Neurodex(TM) New Drug Application | AMEX:AVN | 12% Strides Linked TO Apple, Inc. |
| 16/09/2005 | 22:55 | Business Wire | AVANIR Pharmaceuticals Invites Investors to the Bank of America and the UBS Global Life Sciences Conference Webcasts | AMEX:AVN | 12% Strides Linked TO Apple, Inc. |
| 01/09/2005 | 01:56 | Business Wire | Update on AVANIR's Neurodex(TM) New Drug Application | AMEX:AVN | 12% Strides Linked TO Apple, Inc. |
| 15/08/2005 | 15:00 | Business Wire | AVANIR Pharmaceuticals Reports Third Quarter Fiscal 2005 Financial Results | AMEX:AVN | 12% Strides Linked TO Apple, Inc. |
| 11/07/2005 | 20:26 | Business Wire | AVANIR Announces Corporate Update Conference Call | AMEX:AVN | 12% Strides Linked TO Apple, Inc. |
| 11/07/2005 | 15:15 | Business Wire | AstraZeneca and AVANIR Announce Global Alliance to Discover and Develop Novel Reverse Cholesterol Transport Enhancing Compounds | AMEX:AVN | 12% Strides Linked TO Apple, Inc. |
| 06/07/2005 | 15:00 | Business Wire | AVANIR Strengthens Its Sales and Marketing Team | AMEX:AVN | 12% Strides Linked TO Apple, Inc. |
| 05/07/2005 | 15:00 | Business Wire | AVANIR Pharmaceuticals Added to 2005 Russell Indices | AMEX:AVN | 12% Strides Linked TO Apple, Inc. |
| 30/06/2005 | 13:30 | Business Wire | AVANIR Submits NDA for Neurodex(TM) | AMEX:AVN | 12% Strides Linked TO Apple, Inc. |
| 23/06/2005 | 15:00 | Business Wire | AVANIR Initiates Phase III Clinical Trial of Neurodex for the Treatment of Diabetic Neuropathic Pain | AMEX:AVN | 12% Strides Linked TO Apple, Inc. |
| 21/06/2005 | 00:04 | Business Wire | AVANIR Pharmaceuticals Files Shelf Registration Statement | AMEX:AVN | 12% Strides Linked TO Apple, Inc. |
| 06/06/2005 | 19:11 | Business Wire | AVANIR's Investigational Anthrax Antibody Effective in Recognized Animal Model; UTMB Scientists Present Data at ASM Meeting | AMEX:AVN | 12% Strides Linked TO Apple, Inc. |
| 03/06/2005 | 20:31 | Business Wire | AVANIR Invites Investors to Webcast of Pacific Growth Equities Life Sciences Growth Conference Presentation | AMEX:AVN | 12% Strides Linked TO Apple, Inc. |
| 31/05/2005 | 19:33 | Business Wire | AVANIR Amends Terms of Existing Warrant; Warrant to Expire if Not Exercised by July 26, 2005 | AMEX:AVN | 12% Strides Linked TO Apple, Inc. |
| 13/05/2005 | 14:30 | Business Wire | Webcast Alert: AVANIR Pharmaceuticals Announces Its Second Quarter 2005 Conference Call Webcast | AMEX:AVN | 12% Strides Linked TO Apple, Inc. |
| 10/05/2005 | 23:54 | Business Wire | AVANIR Pharmaceuticals Invites Investors to Its Second Fiscal Quarter 2005 Conference Call on May 16, 2005 | AMEX:AVN | 12% Strides Linked TO Apple, Inc. |
| 29/12/2003 | 11:00 | PR Newswire (US) | New Research Gives Hope to Stroke Survivors with Uncontrolled Emotions | AMEX:AVN | 12% Strides Linked TO Apple, Inc. |
